
Read More
This Low PE Pharma Stock Approves Rs 1,400 Crore South Africa Expansion; St...
NATCO Pharma approved investments of up to Rs 1,400 crore to expand its South African operations, in...

NATCO Pharma approved investments of up to Rs 1,400 crore to expand its South African operations, in...

Natco Pharma received a demand notice from the National Pharmaceutical Pricing Authority related to ...

13 Month Breakout and Golden Crossover: This Low PE Pharma Stock with Low Debt to Equity Ratio Shoul...

The company has a market cap of over Rs 17,443.51 crore. The stock price has surged over 73.17 per c...

At 2.30 pm on Thursday, the markets were seen recovering from the day’s low as Asia- Pacific markets...

After making a cautious start amid mixed global cues, the Indian benchmark indices ended the day on ...

On Tuesday, investors globally remained cautious and on a backfoot tracking news flow on the war of ...